OOIR: Observatory of International Research

Papers

(The H4-Index of Allergy is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
In this Issue: Graphical Abstracts	665
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	330
Legends of allergology and immunology: Per Brandtzaeg – Pillar of mucosal immunology	279
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	245
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	185
Issue Information	174
Large scale regulatory T cells screening	163
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	149
In memoriam: Lawrence M. Lichtenstein (1934–2022)	143
Issue Information	140
Issue Information	137
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	121
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	116
Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity	114
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	112
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	105
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	104
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	104
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	98
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3⁺ Tregs	96
Type 2 memory B cells: The repository of allergic memory?	95
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	91
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	91
Medical algorithm: Peri‐operative management of mastocytosis patients	91
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	87

Health effects of exposure to chlorination by‐products in swimming pools	82
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	81
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	80
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	80
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	80
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	78
TOP10‐SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions	77
Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial	76
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	75
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	71
MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	70
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19	70
Immunoglobulin E response in health and disease beyond allergic disorders	70
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	69
	69
Development and validation of the food allergy severity score	66
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	66
Medical algorithm: Diagnosis and treatment of hypersensitivity reactions to cancer chemotherapy	65
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	64
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	62
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	61
Allergenic components of the mRNA‐1273 vaccine for COVID‐19: Possible involvement of polyethylene glycol and IgG‐mediated complement activation	61
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	61
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	59
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	59
Experimental rhinovirus infection induces an antiviral response in circulating B cells which is dysregulated in patients with asthma	59
Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity	58
Discrepancies in Beta‐Lactam Antibiotics Cross‐Reactivity: Implications for Clinical Practice	58
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	58
Issue Information ‐ TOC	57
In this Issue: Graphical Abstracts	56
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”	56
Issue Information	56
The Molecular Allergology User's Guide version 2.0 is freely available!	56